IGF1 and cancer: A number of possible physiological mechanisms underlying the association of body fat mass with cancer progression have been proposed, including circulating insulin and/or insulin-like growth factor 1, altered adipokine levels (i.e., increased leptin and decreased adiponectin), and systemic and tissue-level inflammation (36, 37).